Investor · 4 deals
Every published round Uniseed/UniSuper took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| PlasmaLeap Technologies | Series A | 4 Aug 2026 | $28m | Participant | RenewEconomy (13 Aug 2026), RenewEconomy (13 Aug 2026), SmartCompany (6 Mar 2026), SmartCompany (4 Mar 2026) | |
| PlasmaLeap Technologies | Series A | 2026 | ~$30m | Participant | GrainCorp Ventures (13 Mar 2026), GrainCorp Ventures (13 Mar 2026), Startup Daily (6 Mar 2026), Startup Daily (3 Mar 2026) | |
| FerronovaPrecision cancer treatment technology | Series A | 17 Dec 2025 | $6m | Lead | movefm.com.au, ferronova.com.au, Artesian VC portfolio, Artesian VC portfolio | |
| Ferronova | Series A | 17 Dec 2025 | $6m | Lead | Wholesale Investor (29 Jan 2026), Wholesale Investor (16 Jan 2026), Startup Daily (19 Dec 2025), SmartCompany, Biotech Dispatch, Uniseed, Startup Daily (17 Dec 2025), Business News Australia, biospectrumasia.com, South Australian Venture Capital Fund portfolio |
Companies Uniseed/UniSuper has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| PlasmaLeap Technologies | Developer of zero-emissions chemical reactors for green fertiliser and fuel production | 2026, Series A | 2 | 0 |
| Ferronova | advance image-guided cancer surgery | 17 Dec 2025, Series A | 1 | 1 |
| FerronovaPrecision cancer treatment technology | 17 Dec 2025, Series A | 1 | 1 |
Fund closes reported for Uniseed/UniSuper, as distinct from the investments it has made.
Companies Uniseed/UniSuper has backed that another company then bought. An exit for the holding, not a deal Uniseed/UniSuper did.
Stories naming Uniseed/UniSuper. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
A weekly roundup detailing new funding rounds for six Australian startups: Lyka, PlasmaLeap, Firmable, Veyor, Lumonus and Future Minds Network, with investors and round details.
PlasmaLeap, a Sydney maker of emissions-free fertiliser technology, has closed a US$20m Series A backed by Gates Foundation, Investible, Yara Growth Ventures and other investors.
Roundup of seven trans-Tasman raises worth $93.1m this week, headlined by IND Technology's $50m round, with LawVu also acquiring ClauseBase.
Adelaide medtech Ferronova has banked another $6 million from returning backers to advance its surgical tracer for cancer, lifting Series A funding to $17.5 million; backer parent UltraGreen.ai floated in Singapore this month.
Also movefm.com.au
Adelaide biotech Ferronova added $6 million to its Series A from prior backers, lifting the round's total to $17.5 million; backer Renew's parent Ultragreen.ai floated in Singapore this month.
Also ferronova.com.au·movefm.com.au·Biotech Dispatch·Startup Daily